{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:36:59Z","timestamp":1792211819331,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.antiviral.2020.104782","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T12:09:27Z","timestamp":1585138167000},"page":"104782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus"],"prefix":"10.1016","volume":"177","author":[{"given":"Amira F.A.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smanla","family":"Tundup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Antanasijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Varhegyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman M.","family":"AbdulRahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat G.","family":"Elenany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheir","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norton","family":"Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Manicassamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104782_bib1","series-title":"Structure of a Small Molecule Fusion Inhibitor in Complex with Avian Influenza Hemagglutinin","author":"Antanasijevic","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104782_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10858-016-0025-1","article-title":"Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions","volume":"64","author":"Antanasijevic","year":"2016","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.antiviral.2020.104782_bib3","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of ebola and Marburg virus entry by G protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104782_bib4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2020.104782_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","article-title":"Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study","volume":"12","author":"Dawood","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104782_bib6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104782_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.antiviral.2020.104782_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2020.104782_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"P Jpn Acad B-Phys"},{"key":"10.1016\/j.antiviral.2020.104782_bib10","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1128\/jvi.71.11.8808-8820.1997","article-title":"Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity","volume":"71","author":"Hoffman","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104782_bib11","first-page":"5115","article-title":"Influenza virus: small molecule therapeutics and mechanisms of antiviral resistance","volume":"25","author":"Julianna","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104782_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol","volume":"114","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104782_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/viro.1996.0628","article-title":"Characterization of a hemagglutinin-specific inhibitor of influenza A virus","volume":"226","author":"Luo","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104782_bib14","doi-asserted-by":"crossref","first-page":"104545","DOI":"10.1016\/j.antiviral.2019.104545","article-title":"Antivirals targeting the polymerase complex of influenza viruses","volume":"169","author":"Mifsud","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104782_bib15","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1073\/pnas.1812632116","article-title":"Real-time dissection of dynamic uncoating of individual influenza viruses","volume":"116","author":"Qin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2020.104782_bib16","doi-asserted-by":"crossref","first-page":"17736","DOI":"10.1073\/pnas.0807142105","article-title":"Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion","volume":"105","author":"Russell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104782_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.onehlt.2015.03.001","article-title":"One health, multiple challenges: the inter-species transmission of influenza A virus","volume":"1","author":"Short","year":"2015","journal-title":"One Health"},{"key":"10.1016\/j.antiviral.2020.104782_bib18","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","author":"Steel","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104782_bib19","doi-asserted-by":"crossref","first-page":"1800698","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800698","article-title":"Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018","volume":"24","author":"Takashita","year":"2019","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2020.104782_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006270","article-title":"Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species","volume":"13","author":"Tundup","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104782_bib21","doi-asserted-by":"crossref","first-page":"eaar6221","DOI":"10.1126\/science.aar6221","article-title":"A small-molecule fusion inhibitor of influenza virus is orally active in mice","volume":"363","author":"van Dongen","year":"2019","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2020.104782_bib22","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/JVI.02325-09","article-title":"Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin","volume":"84","author":"Vanderlinden","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104782_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087057113494405","article-title":"A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses","volume":"19","author":"Wang","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.antiviral.2020.104782_bib24","series-title":"World Health Organization - Influenza (Seasonal)","author":"WHO","year":"2018"},{"key":"10.1016\/j.antiviral.2020.104782_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines","volume":"26","author":"Wong","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104782_bib26","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.jmb.2017.06.015","article-title":"A perspective on the structural and functional constraints for immune evasion: insights from influenza virus","volume":"429","author":"Wu","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104782_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41594-018-0025-9","article-title":"Structural insights into the design of novel anti-influenza therapies","volume":"25","author":"Wu","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104782_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029120","article-title":"Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin","volume":"6","author":"Zhu","year":"2011","journal-title":"PloS One"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219306400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219306400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:45Z","timestamp":1759062705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219306400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":28,"alternative-id":["S0166354219306400"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104782","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104782"}}